Our organization includes the core functions and, in addition, strategic planning, operational excellence, and SHE. This enables flexible solutions through well-established decisions. The company is led by the CEO and the executive leadership team and locally by site leadership teams.

Kenneth Stokholm

Kenneth joined Sever Pharma Solutions as CEO in 2009 and brings 25 years of pharmaceutical industry experience. He has served in several roles at Nordic Group, including SVP of Technical operations and Strategic Development. Prior to this, he spent eight years in several international positions with Xellia pharmaceuticals, incl GM China, and five years in different technical roles with Novo Nordisk. Kenneth holds an MSc in chemical engineering from the technical university of Denmark (DTU) and an executive MBA from HEC in Paris.

Christian Frandsen

Christian joined Sever Pharma Solutions as Group CFO in 2020 and brings more than 15 years of pharmaceutical industry experience. He has served in several roles at Novo Nordisk, including CFO of Novo Nordisk Pharmatech A/S, Finance & Operations Director positions in Novo Nordisk Sweden and Mexico and various management roles in HQ procurement. Prior to this, he was employed at the Confederations of Danish Industries. Christian holds a Ma (Law) from University of Copenhagen and an executive MBA from Scandinavian Management Institute in Copenhagen (SIMI).

Guido van der Aar
VP BD & Commercial

Guido joined Sever Pharma Solutions in July 2019 as site Manager for the Dutch site and became VP BD & Commercial in Jan 2021. Guido has a track record in management, sales and marketing positions for over 25 years. All over his career customer focused strategy has been the focus point of his thinking and activities. Creating strong partnerships with customers is on the top of his lists of priorities. He was responsible for the development of a (global) Key Account management program at Organon, became General Manager for Nordic Pharma in the Netherlands and was responsible for BD activities, both in the Netherlands as internationally.

Tony Listro
VP, Technology

Tony is responsible for the development of new melt extrusion technologies at Sever Pharma Solutions’ Putnam, CT site. Tony is an expert in the areas of polymer materials and polymer processing. He has worked on polymer-based drug delivery systems and dosage forms for more than 15 years. Tony holds both a BS and MS in Plastics Engineering from the University of Massachusetts in Lowell, MA, and an MBA from the University of Massachusetts in Amherst, MA. He holds 2 issued US patents and has authored and/or co-authored 20 publications.

Joseph McCluskey
VP Operations

Joseph joined Sever Pharma Solutions in May 2020 bringing with him over 20 years of pharmaceutical industry experience. Prior to joining Sever Pharma Solutions Joseph has had a long career with Fresenius Kabi where he held various roles with increasing levels of responsibility, including heading up multiple sites across Scandinavia and Asia. He has also held headed up the internal API manufacturing for AstraZeneca in Sweden. Joseph holds an MSc in Manufacturing from the Open University UK and BSc in Engineering Systems from Edinburgh Napier University.

Wouter de Graaff

Wouter is a seasoned expert in controlled release drug delivery and inventor of more than 15 patents related to controlled release formulations. Before joining Sever Pharma Solutions in 2015 he headed the pharmaceutical development of polymer-based delivery systems within MSD (Merck) and the legacy companies Schering Plough and Organon. At Sever Pharma Solutions he is responsible for Research and Development, including Regulatory Affairs. Wouter graduated from the University of Amsterdam and holds an MSc in chemical engineering.

Linda Rebert

Linda joined Sever Pharma Solutions in April 2020 and have more than 20 years of experience, mainly in the pharmaceutical industry but also in the food ingredient industry. She has held several roles at Polypeptide Laboratories AB such a Development Chemist, Manager of Synthesis Department and Global Process Excellence Manager. Most recently, she worked as Lean Director in Chr. Hansen A/S. Linda holds an MCs in Chemical Engineering from Lund University and has a Black Belt certification in Lean Six Sigma.

Lotte Nyman Göransson

Lotte joined Sever Pharma Solutions as Head of Quality Assurance in October 2019. She has 20 years of experience from the pharmaceutical industry in the areas of quality assurance, production and R&D. She started with development of biotech processes at AstraZeneca Biotech Lab and then continued to the field of consulting at NNE Pharmaplan in Denmark.  Lotte later joined Xellia Pharmaceuticals where she held various positions, among them department manager of CQA. Her most recent position was at Bristol Myers Squibb in Switzerland working with Tech Transfers of Sterile Biologics. Lotte holds an MSc in Chemical Engineering from Lund University.

Jessica Jonasson
Global HR Director

Jessica joined Sever Pharma Solutions as Global HR Director in August 2022. Jessica has held several international positions in various industries, latest as Chief Human Resources Officer for ROCKWOOL Group. Before that she had a longer career in different roles with ASSA ABLOY, Jysk and Walmart, including heading up all HR operations globally. Besides HR competencies, Jessica brings experience of business leadership and change management. Jessica holds a Bachelor of Science in Human Resource development and Employment Law from Uppsala University in Sweden.